Metastatic NSCLC patients in the real world in Finland.

ABSTRACT:

Background

Significant progress has been made in the management of metastatic NSCLC (mNSCLC). Our study investigated characteristics, treatment patterns, and outcomes in this patient population and subgroups based on histology and PD-L1 status.

Methods

We conducted a retrospective analysis of electronic health records of patients with mNSCLC 1/2019-8/2023 at HUS, Helsinki University Hospital, Finland. Patient characteristics, treatment, and outcomes were analyzed.

Results

We identified 646 patients with mNSCLC, including those metastatic at diagnosis and whose cancer later progressed to metastatic, who received systemic therapy. Median age was 70 years (interquartile range [IQR]: 62-75). Squamous cell carcinoma (SqC) presented 19% of patients, adenocarcinoma 68%, and

SUBMITTER: Ekroos H 

PROVIDER: S-EPMC12717630 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature